Latest AI and machine learning research in oncology/hematology for healthcare professionals.
Clear cell renal cell carcinoma (ccRCC) is the leading cause of kidney cancer-related death, but how the tumor microenvironment shapes patient survival is not completely understood. Here, we describe the characterization of ccRCC tumor ecosystems from 498 patients using imaging mass cytometry with a focus on tumor, myeloid, and T cell landscapes. Data from more than 3 million single cells is analy...
Tumour typing from whole-genome sequencing is increasingly accurate, yet molecular subtyping from somatic variants remains challenging because of tumour heterogeneity and inconsistent clinical annotations. Here, we present Mutation-Attention Dual-Task (MuAt2), a Transformer model that jointly classifies histological tumour types and subtypes directly from somatic single-nucleotide variants, indels...
The discovery of novel small molecules is challenging because of the vastness of chemical space and the complexity of protein-ligand interactions, lea...
Cell migration is a key biological process underlying wound healing, tissue development, and cancer metastasis, yet calibrating mathematical models of...
Accurate brain tumor typing requires integrating heterogeneous clinical evidence, including magnetic resonance imaging (MRI), histopathology, and path...
Glioblastoma exhibits diverse, infiltrative, and patient-specific growth patterns that are only partially visible on routine MRI, making it difficult ...
Background and objective: Cell-level pathological image analysis requires working with extremely small image patches (40x40 pixels), far below standar...
Pancreatic ductal adenocarcinoma (PDAC) is an aggressive malignancy characterized by profound molecular heterogeneity and inconsistent responses to ge...
Summary Background Once the treatment starts, early prediction of treatment benefit and its correlation with overall survival (OS) remains challenging...
The development and validation of prognostic and predictive biomarkers in breast cancer is limited by the availability of well-annotated datasets link...
Background: N4-acetylcytidine (ac4C) modification plays a critical role in cancer development. Exploring ac4C modification in laryngeal squamous cell ...
Generalist pathology foundation models (PFMs), pretrained on large-scale multi-organ datasets, have demonstrated remarkable predictive capabilities ac...
Lung cancer is characterized by profound intratumoral and inter-patient heterogeneity, spanning histological subtypes, molecular landscapes, and the t...
Lower-grade gliomas (World Health Organization [WHO] grades 2-3) exhibit variable treatment responses, yet clinical decisions remain guided by populat...
Mapping of T cell receptors (TCRs) to their cognate MHC-presented peptides (pMHC) is central for the development of precision immunotherapies and vacc...
Extrachromosomal DNA (ecDNA) is a major driver of oncogene amplification, tumour heterogeneity and poor clinical outcomes [1-3], yet its detection rel...
Accurate classification of pediatric central nervous system tumors remains challenging due to histological complexity and limited training data. While...
White blood cell (WBC) classification is fundamental for hematology applications such as infection assessment, leukemia screening, and treatment monit...
While multimodal survival prediction models are increasingly more accurate, their complexity often reduces interpretability, limiting insight into how...
Breast cancer is the most frequently diagnosed malignancy among women worldwide and a leading cause of cancer-related mortality. Dynamic contrast-enha...